Showing 1 - 10 results of 10 for search 'Anita K Wagner', query time: 0.04s Refine Results
  1. 1
    30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?

    30 years of media coverage on high drug prices in the US – a never-ending story or a time for change? by Christine Leopold, James D Chambers, Anita K Wagner

    Published 2015-12-01
    Get full text
    Article
  2. 2
    Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand

    Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand by Christine Leopold, Christine Y. Lu, Anita K. Wagner

    Published 2020-04-01
    Get full text
    Article
  3. 3
    Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway

    Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway by Mahnum Shahzad, Huseyin Naci, Katharine M. Esselen, Joseph A. Dottino, Anita K. Wagner

    Published 2024-12-01
    Get full text
    Article
  4. 4
    1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities

    1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities by Birna Trap, Moses N. Sembatya, Monica Imi, Morries Seru, Anita K. Wagner, Dennis Ross-Degnan

    Published 2020-12-01
    Get full text
    Article
  5. 5
    Need for and access to health care and medicines: are there gender inequities?

    Need for and access to health care and medicines: are there gender inequities? by Anita K Wagner, Amy J Graves, Zhengyu Fan, Saul Walker, Fang Zhang, Dennis Ross-Degnan

    Published 2013-01-01
    Get full text
    Article
  6. 6
    The Brazilian private pharmaceutical market after the first ten years of the generics law

    The Brazilian private pharmaceutical market after the first ten years of the generics law by Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens, Dennis Ross-Degnan

    Published 2019-12-01
    Get full text
    Article
  7. 7
    Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001–2020Research in context

    Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001–2020Research in context by Yuxuan Wei, Yichen Zhang, Ziyue Xu, Guoan Wang, Yue Zhou, Huangqianyu Li, Luwen Shi, Huseyin Naci, Anita K. Wagner, Xiaodong Guan

    Published 2024-04-01
    Get full text
    Article
  8. 8
    Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries

    Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries by Christine Leopold, Aukje K Mantel-Teeuwisse, Sabine Vogler, Silvia Valkova, Kees de Joncheere, Hubert GM Leufkens, Anita K Wagner, Dennis Ross-Degnan, Richard Laing

    Published 2014-09-01
    Get full text
    Article
  9. 9
    Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China

    Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China by Dr. Yu Fang, PhD, Anita K Wagner, DrPH, Shimin Yang, BS, Minghuan Jiang, MS, Fang Zhang, PhD, Dennis Ross-Degnan, ScD

    Published 2013-10-01
    Get full text
    Article
  10. 10
    Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context

    Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context by Adriana M. Ivama-Brummell, Fernanda L. Marciniuk, Anita K. Wagner, Claudia G.S. Osorio-de-Castro, Sabine Vogler, Elias Mossialos, Carla L. Tavares-de-Andrade, Huseyin Naci

    Published 2023-06-01
    Get full text
    Article

Search Tools: